Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cholesterol Hydroxylating Cytochrome P450 46A1: From Mechanisms of Action to Clinical Applications
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-08
DOI
10.3389/fnagi.2021.696778
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice
- (2021) Tahir Ali et al. Acta Neuropathologica Communications
- Synthesis and pharmacokinetic study of a 11C-labeled cholesterol 24-hydroxylase inhibitor using ‘in-loop’ [11C]CO2 fixation method
- (2020) Zhen Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Localization of sterols and oxysterols in mouse brain reveals distinct spatial cholesterol metabolism
- (2020) Eylan Yutuc et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutamate affects cholesterol homeostasis within the brain via the up-regulation of CYP46A1 and ApoE
- (2020) Junjie Zhang et al. TOXICOLOGY
- Epilepsy: key experimental therapeutics in early clinical development
- (2020) Claude Steriade et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Serum 24S-hydroxycholesterol predicts long-term brain structural and functional outcomes after hypoxia-ischemia in neonatal mice
- (2020) Fuxin Lu et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice
- (2020) Toshiya Nishi et al. Scientific Reports
- Diverse Immunoregulatory Roles of Oxysterols—The Oxidized Cholesterol Metabolites
- (2020) Chloe Choi et al. Metabolites
- The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System
- (2020) Françoise Piguet et al. HUMAN GENE THERAPY
- 24S‐hydroxycholesterol: Cellular effects and variations in brain diseases
- (2020) Alejandro O. Sodero JOURNAL OF NEUROCHEMISTRY
- Brain cholesterol metabolism and Parkinson's disease
- (2019) Xuemei Huang et al. MOVEMENT DISORDERS
- Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment
- (2019) Raúl Loera-Valencia et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cholesterol and the Safety Factor for Neuromuscular Transmission
- (2019) Igor Krivoi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cholesterol Metabolism Is a Druggable Axis that Independently Regulates Tau and Amyloid-β in iPSC-Derived Alzheimer’s Disease Neurons
- (2019) Rik van der Kant et al. Cell Stem Cell
- The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment
- (2019) Alexey M. Petrov et al. FASEB JOURNAL
- Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia
- (2019) Clévio Nóbrega et al. ACTA NEUROPATHOLOGICA
- CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington’s disease
- (2019) Radhia Kacher et al. BRAIN
- CYP46A1 Activation by Efavirenz Leads to Behavioral Improvement without Significant Changes in Amyloid Plaque Load in the Brain of 5XFAD Mice
- (2019) Alexey M. Petrov et al. Neurotherapeutics
- Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases
- (2019) Alexey M. Petrov et al. Neurotherapeutics
- NPC 1 enables cholesterol mobilization during long‐term potentiation that can be restored in Niemann–Pick disease type C by CYP 46A1 activation
- (2019) Daniel N Mitroi et al. EMBO REPORTS
- In Vitro Activation of Cytochrome P450 46A1 (CYP46A1) by Efavirenz-Related Compounds
- (2019) Natalia Mast et al. JOURNAL OF MEDICINAL CHEMISTRY
- Amyloid-β-independent regulators of tau pathology in Alzheimer disease
- (2019) Rik van der Kant et al. NATURE REVIEWS NEUROSCIENCE
- Oxysterols as lipid mediators: Their biosynthetic genes, enzymes and metabolites
- (2019) William J. Griffiths et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Plasma oxysterol profiling in children reveals 24-hydroxycholesterol as a potential marker for Autism Spectrum Disorders
- (2018) S. Grayaa et al. BIOCHIMIE
- Identification of Correlative Shifts in Indices of Brain Cholesterol Metabolism in the C57BL6/Mecp2 tm1.1Bird Mouse, a Model for Rett Syndrome
- (2018) Dieter Lütjohann et al. LIPIDS
- 24S-hydroxycholesterol suppresses neuromuscular transmission in SOD1(G93A) mice: A possible role of NO and lipid rafts
- (2018) Kamilla A. Mukhutdinova et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer’s Disease
- (2018) Ling Li et al. MOLECULAR NEUROBIOLOGY
- The level of 24-hydroxycholesteryl esters decreases in plasma of patients with Parkinson’s disease
- (2018) Concetta Di Natale et al. NEUROSCIENCE LETTERS
- Upregulation of cholesterol 24-hydroxylase following hypoxia–ischemia in neonatal mouse brain
- (2018) Fuxin Lu et al. PEDIATRIC RESEARCH
- Biomarkers of Amyotrophic Lateral Sclerosis: Current Status and Interest of Oxysterols and Phytosterols
- (2018) Anne Vejux et al. Frontiers in Molecular Neuroscience
- CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content
- (2018) Lydie Boussicault et al. BIOCHIMIE
- Diagnostic Power of 24S-Hydroxycholesterol in Cerebrospinal Fluid: Candidate Marker of Brain Health
- (2018) Valerio Leoni et al. JOURNAL OF ALZHEIMERS DISEASE
- 24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome
- (2018) Ingemar Björkhem et al. Frontiers in Neurology
- Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical development
- (2018) Meir Bialer et al. EPILEPSIA
- On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review)
- (2018) Ingemar Björkhem et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Somatic APP gene recombination in Alzheimer’s disease and normal neurons
- (2018) Ming-Hsiang Lee et al. NATURE
- Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons
- (2018) Xiaofei Wei et al. NEUROPHARMACOLOGY
- Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects
- (2017) Nadezda Apostolova et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The mevalonate pathway in neurons: It's not just about cholesterol
- (2017) Miguel Moutinho et al. EXPERIMENTAL CELL RESEARCH
- In vitrocytochrome P450 46A1 (CYP46A1) activation by neuroactive compounds
- (2017) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease
- (2017) Natalia Mast et al. NEUROPHARMACOLOGY
- Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice
- (2017) Tejal K. Patel et al. Pharmacological Reports
- Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)
- (2017) Natalia Mast et al. PLoS One
- Neuronal Cholesterol Accumulation Induced by Cyp46a1 Down-Regulation in Mouse Hippocampus Disrupts Brain Lipid Homeostasis
- (2017) Sophie Ayciriex et al. Frontiers in Molecular Neuroscience
- Chromatin-Modifying Agents Increase Transcription of CYP46A1, a Key Player in Brain Cholesterol Elimination
- (2017) Inês Milagre et al. JOURNAL OF ALZHEIMERS DISEASE
- Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond
- (2016) Miguel Moutinho et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
- (2016) Lydie Boussicault et al. BRAIN
- The role of cholesterol in membrane fusion
- (2016) Sung-Tae Yang et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology
- (2016) Hui Yang et al. FEBS Journal
- Mapping of the Allosteric Site in Cholesterol Hydroxylase CYP46A1 for Efavirenz, a Drug That Stimulates Enzyme Activity
- (2016) Kyle W. Anderson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices
- (2016) Min-Yu Sun et al. JOURNAL OF NEUROPHYSIOLOGY
- Interdependence of oxysterols with cholesterol profiles in multiple sclerosis
- (2016) Shreya Mukhopadhyay et al. Multiple Sclerosis Journal
- Interdependence of oxysterols with cholesterol profiles in multiple sclerosis
- (2016) Shreya Mukhopadhyay et al. Multiple Sclerosis Journal
- Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation
- (2016) Gabriella Testa et al. Redox Biology
- CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease
- (2015) Fathia Djelti et al. BRAIN
- Interaction between positive allosteric modulators and trapping blockers of the NMDA receptor channel
- (2015) Christine M Emnett et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus
- (2015) Farah Chali et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology
- (2015) Marie-Anne Burlot et al. HUMAN MOLECULAR GENETICS
- Efavirenz and the CNS: what we already know and questions that need to be answered
- (2015) Nadezda Apostolova et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function
- (2015) Junji Egawa et al. JOURNAL OF PHYSIOLOGY-LONDON
- Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis
- (2015) Lenka Novakova et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- 24(S)-Hydroxycholesterol as a Modulator of Neuronal Signaling and Survival
- (2015) Min-Yu Sun et al. NEUROSCIENTIST
- Cholesterol Homeostasis Failure in the Brain: Implications for Synaptic Dysfunction and Cognitive Decline
- (2014) Marco Segatto et al. CURRENT MEDICINAL CHEMISTRY
- Different oxysterols have opposing actions at N-methyl-d-aspartate receptors
- (2014) Andrew J. Linsenbardt et al. NEUROPHARMACOLOGY
- Efavirenz Promotes β-Secretase Expression and Increased Aβ1-40,42 via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)
- (2014) Lecia A. M. Brown et al. PLoS One
- Potential diagnostic applications of side chain oxysterols analysis in plasma and cerebrospinal fluid
- (2013) Valerio Leoni et al. BIOCHEMICAL PHARMACOLOGY
- Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1
- (2013) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacologic Stimulation of Cytochrome P450 46A1 and Cerebral Cholesterol Turnover in Mice
- (2013) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors
- (2013) S. M. Paul et al. JOURNAL OF NEUROSCIENCE
- Spatiotemporal Dynamics of Phosphorylation in Lipid Second Messenger Signaling
- (2013) Corina E. Antal et al. MOLECULAR & CELLULAR PROTEOMICS
- Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis
- (2013) C van de Kraats et al. Multiple Sclerosis Journal
- Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression
- (2013) Valerio Leoni et al. NEUROBIOLOGY OF DISEASE
- NMDA receptors in nervous system diseases
- (2013) Qiang Zhou et al. NEUROPHARMACOLOGY
- Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
- (2013) Ingemar Björkhem et al. NEUROSCIENCE LETTERS
- Is It Possible to Improve Memory Function by Upregulation of the Cholesterol 24S-Hydroxylase (CYP46A1) in the Brain?
- (2013) Silvia Maioli et al. PLoS One
- 24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases
- (2012) Valerio Leoni et al. BIOCHIMIE
- Cholesterol loss during glutamate-mediated excitotoxicity
- (2012) Alejandro O Sodero et al. EMBO JOURNAL
- Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease
- (2012) Julius Popp et al. JOURNAL OF NEUROCHEMISTRY
- Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case-control study
- (2011) Giovanni Zuliani et al. BMC Neurology
- Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter
- (2011) Inês Milagre et al. JOURNAL OF NEUROCHEMISTRY
- Cholesterol metabolism in Huntington disease
- (2011) Joanna M. Karasinska et al. Nature Reviews Neurology
- Role of carglumic acid in the treatment of acute hyperammonemia due to N-acetylglutamate synthase deficiency
- (2011) Johannes Häberle Therapeutics and Clinical Risk Management
- Structural Basis of Drug Binding to CYP46A1, an Enzyme That Controls Cholesterol Turnover in the Brain
- (2010) Natalia Mast et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT1 Modulation as a Novel Approach to the Treatment of Diseases of Aging
- (2010) Charles A. Blum et al. JOURNAL OF MEDICINAL CHEMISTRY
- Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington’s disease
- (2010) Daniel Del Toro et al. JOURNAL OF NEUROCHEMISTRY
- Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression ofCYP46A1gene transcription
- (2010) Maria João Nunes et al. JOURNAL OF NEUROCHEMISTRY
- Memantine Preferentially Blocks Extrasynaptic over Synaptic NMDA Receptor Currents in Hippocampal Autapses
- (2010) P. Xia et al. JOURNAL OF NEUROSCIENCE
- Cellular stress from excitatory neurotransmission contributes to cholesterol loss in hippocampal neurons aging in vitro
- (2010) Alejandro O. Sodero et al. NEUROBIOLOGY OF AGING
- Cholesterol 24-Hydroxylase: An Enzyme of Cholesterol Turnover in the Brain
- (2009) David W. Russell et al. Annual Review of Biochemistry
- The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo
- (2009) Marjan Shafaati et al. JOURNAL OF LIPID RESEARCH
- Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats
- (2009) Katja Nieweg et al. JOURNAL OF NEUROCHEMISTRY
- Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease
- (2009) Eloise Hudry et al. MOLECULAR THERAPY
- Different Patterns of Oxidized Lipid Products in Plasma and Urine of Dengue Fever, Stroke, and Parkinson's Disease Patients: Cautions in the Use of Biomarkers of Oxidative Stress
- (2008) Chung-Yung J. Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- Transcriptional regulation of cholesterol 24-hydroxylase by histone deacetylase inhibitors
- (2008) Marjan Shafaati et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease
- (2008) Valerio Leoni et al. BRAIN
- Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain
- (2008) Denise M.O. Ramirez et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Transcriptional regulation of the humanCYP46A1brain-specific expression by Sp transcription factors
- (2008) Ins Milagre et al. JOURNAL OF NEUROCHEMISTRY
- Cortical Injury Increases Cholesterol 24S Hydroxylase (Cyp46) Levels in the Rat Brain
- (2008) Casandra M. Cartagena et al. JOURNAL OF NEUROTRAUMA
- Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation
- (2008) T. Kotti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain
- (2008) N. Mast et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started